Arcadia Biosciences (RKDA) Asset Utilization Ratio (2015 - 2025)

Arcadia Biosciences has reported Asset Utilization Ratio for 11 years, with the latest figure at 0.64 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 82.99% year-over-year to 0.64; the trailing twelve-month figure through Dec 2025 stood at 0.64 (up 82.99% YoY), and the FY2025 full-year result was 0.48, up 59.45% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.64, up from 0.63 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 20.48 in Q1 2022, with the low at 0.08 in Q3 2023.
• Historically, Asset Utilization Ratio has averaged 3.31 across 5 years, with a median of 0.36 in 2022.
• Annual changes were most pronounced in 2021 — Asset Utilization Ratio surged 35218.52% — and 2023, when it sank 121.19%.
• Arcadia Biosciences' Asset Utilization Ratio stood at 16.37 in 2021, then tumbled by 99.45% to 0.09 in 2022, then jumped by 138.4% to 0.21 in 2023, then soared by 64.53% to 0.35 in 2024, then soared by 82.99% to 0.64 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.64 (Q4 2025), 0.63 (Q3 2025), and 0.52 (Q2 2025), per Business Quant data.